Login

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE

Vol. 3 No. 6 (2025): International Journal of Cognitive Neuroscience and Psychology:

Ibokhimov Dilshod Dilmurod ogli (1), Urolov Zhavlonbek Yuzbay ogli (2), Omonkulova Shokhsanam Otajon qizi (3), Khabibullaev Fayoziddin Tolibjon ogli (4), Kasimov Arslanbek Atabaevich (5)

(1) Clinical Resident, Department of Neurology Samarkand State Medical University, Uzbekistan
(2) Clinical Resident, Department of Neurology Samarkand State Medical University, Uzbekistan
(3) Clinical Resident, Department of Neurology Samarkand State Medical University, Uzbekistan
(4) Clinical Resident, Department of Neurology Samarkand State Medical University, Uzbekistan
(5) PhD, Associate Professor, Department of Neurology Samarkand State Medical University, Uzbekistan
Fulltext View | Download

Abstract:

This literature review presents current concepts of antiplatelet therapy as an important component of secondary prevention of ischemic stroke. Based on evidence-based medicine data, characteristics of antiplatelet agents included in clinical guidelines and standards for treating patients with ischemic stroke are presented. The main principles of selection and tactics for prescribing antiplatelet drugs to patients with ischemic stroke at different stages of the disease are provided.